期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

重视非抗心律失常药物的抗心律失常作用 被引量：7

暂未订购
导出
摘要 经典的抗心律失常药物在心律失常的治疗中发挥了重要作用。Vaughan Williams根据抗心律失常药物对离子通道的影响和电生理学特点,将经典的抗心律失常药物进行了分类。但是,随着以CAST研究为代表的抗心律失常药物临床试验的认识,
作者 李广平
机构地区 天津医科大学第二医院心脏科
出处 《天津医药》 CAS 北大核心 2011年第4期381-384,共4页 Tianjin Medical Journal
关键词 心律失常 心性 心房颤动 血管紧张素转换酶抑制药 血管紧张素Ⅱ1型受体拮抗剂 脂肪酸类 不饱和羟甲基戊二酰基CoA还原酶抑制剂 噻唑烷二酮类 受体 醛固酮 抗心律失常药
分类号 R972.2 [医药卫生—药品]
  • 相关文献

参考文献36

  • 1Mitchell LB.Role of drug therapy for sustained ventrieular tachyarrhythmias[J].Cardiol Clin,2008,26(3):405-418.
  • 2Domanski MJ.Exner DV,Borkowf CB,el at.Effect of angintensin converting enzyme inhibition on sudden cardiac death in patients following acute myocardial infarction:a recta-analysis of randomized clinical trials[J].J Am Coil Cardiol,1999,33(3):598-604.
  • 3Garg R,Yusuf S.Overview of randomized trials of angiotensin-convetting enzyme inhibitors on mortality and morbidity in patients with heart Failure.Collaborative Group on ACE Inhibitor Trials[J].JAMA,1995,273(18):1450-1456.
  • 4Ten KK,Mitchell LB,Pogue J,et al.Effect of ramipril in reducing sudden deaths and nonfatal cardiac,arrests in high-risk individuals without heart failure or left ventricular dysfunction[J].Circulation,2004,110(11):1413-1417.
  • 5Zakynthinos E,Pierrutsakos Ch,Daniil Z,et al.Losartan controlled blood pressure and reduced eft ventricular hypertrophy but did not alter arhythmias in hypertensive men with preserved sysolic function[J].Angiology,2005,56(4):439-449.
  • 6Healey JS,Baranchuk A,Crystal E,et al.Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers:a meta-analysis[J].J Am Coll Cardiol,2005,45(11):1832-1839.
  • 7杨胜荣,李广平,刘恩照,杨万松.依贝沙坦对慢性房颤犬模型心房电重构的影响[J].天津医药,2008,36(9):689-691. 被引量：4
  • 8Liu E,Yang S,Xu Z,et al.Angiotensiu-(1-7) prevents atrial fibrosis and atrial fibrillation in long-term atrial tachycardia dogs[J].Regul Pept,2010,162(1-3):73-78.
  • 9Liu E,Xu Z,Li J.et al.Enalapril,irbesartan,and angiotensin-(1-7)prevent atrial taehycardia-induced ionic remodeling[J].Int J Cardiol.2011,246(3):364-370.
  • 10Savelieva I,Camm J.Statins and polyunsaturated fatty acids for treatment of atrial fibrillation[J].Nat Clin Pratt Canlinvasc Med,2008,5(1):30-41.

二级参考文献8

  • 1Wijffels MC, Kirchhof C J, Dorland R, et al. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats [J]. Circulation, 1995, 92(10): 1954-1968.
  • 2Schotten U, Ausma J, Stellbrink C, et al. Cellular mechamisms of depressed atrial contractility in patients with chronic atrial fibrillation [J]. Circulation, 2001, 103(2): 691-698.
  • 3Gaspo R, Bosch RF, Talajjic M, et al. Functional mechanisms underlying tachycardia induced sustained atrial fibrillation in a chronic dog model [J]. Circulation, 1997, 96(12): 4027-4035.
  • 4Goette A, Staack T, Rocken C, et al. Increased expression of extracellular signal -regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation [J]. J Am Coll Cardiol, 2000, 35(15): 1669-1677.
  • 5Liu T, Li GP. Anti-inflammatory effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: potential benefits for the prevention of atrial fibrillation [J]. Eur Heart J, 2006, 27 (19): 2370-2371.
  • 6Liu T, Li GP, Li LJ,et al. Association between C-reactive protein and recurrence of atrial fibrillation after successful electrical ardioversion. A Meta-analysis [J]. J Am Coll Cardiol, 2007, 49(15): 1642- 1648.
  • 7Goette A, Arndt M, Rocken C, et al. Regulation of angiontensin Ⅱ receptor subtypes during atrial fibrillation in humans [J]. Circulation, 2000, 101(5): 2778-2781.
  • 8吴冬燕,陈元禄,李广平.快速刺激对豚鼠心房肌动作电位的影响及地尔硫卓、艾司洛尔的干预作用[J].中国心脏起搏与心电生理杂志,2002,16(4):294-297. 被引量：1

共引文献3

同被引文献52

  • 1周自强,胡大一,陈捷,张仁汉,李奎宝,赵秀丽.中国心房颤动现状的流行病学研究[J].中华内科杂志,2004,43(7):491-494. 被引量：1408
  • 2谢英,李曦,张维君,温绍君,赵瑞祥,周玉杰,彭新界,张文,张妍,文杰,程秀琴,王龙华,刘雅.非瓣膜病心房颤动与内皮功能关系的研究[J].临床心血管病杂志,2006,22(5):270-272. 被引量：3
  • 3高亢.厄贝沙坦对非瓣膜性心房纤颤的复发率和左房重构及凝血功能的影响[J].实用心脑肺血管病杂志,2006,14(11):873-874. 被引量：2
  • 4陆再英,钟南山.内科学[M].7版.北京:人民卫生出版社,2008:775.
  • 5Iqba MB, Taneja AK, Gregory, et al. Recent developments in atrial fibrillation, full. British Medical Journal ,2005,300:238-243.
  • 6Fauchier L, Pierre B, de Labriolle A, et al. Antiarrhythmic effect of statin therapy and atrial fibrillation a meta-analysis of randomized controlled trials. J Am Coil Cardiol,2008 ,51:828-835.
  • 7Jones PW, Harding G, Berry P, et al. Development and first valida- tion of the COPD assessment test [ J ]. Eur Respir J,2009,34 ( 3 ) : 648 - 654.
  • 8Asghar O,Alam U,Hayat SA. Obesity,Diabetes and Atrial Fibrillation;Epidemiology,Mechanisms and Interventions[J].Curr Cardiol Rev,2012.
  • 9Strobeck JE. Stroke prevention in atrial fibrillation:managing the risks in light of new oral anticoagulants[J].{H}Cardiovascular Drugs and Therapy,2012,(04):331-338.
  • 10Fauchier L,Pierre B,de Labriolle A. Antiarrhythmic effect of statin therapy and atrial fibrillation a meta-analysis of randomized controlled trials[J].{H}Journal of the America College of Cardiology,2008,(08):828-835.

引证文献7

二级引证文献33

天津医药
2011年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部